Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Murphy

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
BMC Psychiatry|September 4, 2012
A decision aid to assist decisions on disclosure of mental health status to an employer: protocol for the CORAL exploratory randomised controlled trialClaire Henderson, Elaine Brohan, Sarah Clement, et al.
Contemporary Clinical Trials|December 13, 2016
Effectiveness of adjunctive, personalised psychosocial intervention for non-response to opioid agonist treatment: Study protocol for a pragmatic randomised controlled trialJohn Marsden, Garry Stillwell, Jennifer Hellier, et al.
The Lancet. Diabetes & Endocrinology|March 10, 2018
Clinical efficacy and safety of a light mask for prevention of dark adaptation in treating and preventing progression of early diabetic macular oedema at 24 months (CLEOPATRA): a multicentre, phase 3, randomised controlled trialSobha Sivaprasad, Joana C Vasconcelos, A Toby Prevost, et al.
Trials|November 24, 2014
A multicentre phase III randomised controlled single-masked clinical trial evaluating the clinical efficacy and safety of light-masks at preventing dark-adaptation in the treatment of early diabetic macular oedema (CLEOPATRA): study protocol for a randomised controlled trialSobha Sivaprasad, Geoffrey Arden, A Toby Prevost, et al.
Health Technology Assessment (Winchester, England)|February 1, 2019
Extended-release naltrexone versus standard oral naltrexone versus placebo for opioid use disorder: the NEAT three-arm RCTJohn Strang, Michael Kelleher, Soraya Mayet, et al.
Journal of Autism and Developmental Disorders|May 7, 2026
Long-Term Stability of IQ Scores for Children With Neurodevelopmental Disabilities: Stable Global IQ But Unstable Index, Subtest, and Profile IQ ScoresKevin G Stephenson, Megan Norris, Soo Youn Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 4, 2024
Deafness due to loss of a TRPV channel eliminates mating behavior in <i>Aedes aegypti</i> malesYijin Wang, Dhananjay Thakur, Emma Duge, et al.
Journal of Experimental Child Psychology|June 16, 2017
Young infants' visual fixation patterns in addition and subtraction tasks support an object tracking accountJ Gavin Bremner, Alan M Slater, Rachel A Hayes, et al.
Trials|March 26, 2024
The ARIA trial protocol: a randomised controlled trial to assess the clinical, technical, and cost-effectiveness of a cloud-based, ARtificially Intelligent image fusion system in comparison to standard treatment to guide endovascular Aortic aneurysm repairJames Budge, Tom Carrell, Medeah Yaqub, et al.
Lancet (London, England)|May 13, 2017
Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trialSobha Sivaprasad, A Toby Prevost, Joana C Vasconcelos, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
BMC Psychiatry|September 4, 2012
A decision aid to assist decisions on disclosure of mental health status to an employer: protocol for the CORAL exploratory randomised controlled trialClaire Henderson, Elaine Brohan, Sarah Clement, et al.
Contemporary Clinical Trials|December 13, 2016
Effectiveness of adjunctive, personalised psychosocial intervention for non-response to opioid agonist treatment: Study protocol for a pragmatic randomised controlled trialJohn Marsden, Garry Stillwell, Jennifer Hellier, et al.
The Lancet. Diabetes & Endocrinology|March 10, 2018
Clinical efficacy and safety of a light mask for prevention of dark adaptation in treating and preventing progression of early diabetic macular oedema at 24 months (CLEOPATRA): a multicentre, phase 3, randomised controlled trialSobha Sivaprasad, Joana C Vasconcelos, A Toby Prevost, et al.
Trials|November 24, 2014
A multicentre phase III randomised controlled single-masked clinical trial evaluating the clinical efficacy and safety of light-masks at preventing dark-adaptation in the treatment of early diabetic macular oedema (CLEOPATRA): study protocol for a randomised controlled trialSobha Sivaprasad, Geoffrey Arden, A Toby Prevost, et al.
Health Technology Assessment (Winchester, England)|February 1, 2019
Extended-release naltrexone versus standard oral naltrexone versus placebo for opioid use disorder: the NEAT three-arm RCTJohn Strang, Michael Kelleher, Soraya Mayet, et al.
Journal of Autism and Developmental Disorders|May 7, 2026
Long-Term Stability of IQ Scores for Children With Neurodevelopmental Disabilities: Stable Global IQ But Unstable Index, Subtest, and Profile IQ ScoresKevin G Stephenson, Megan Norris, Soo Youn Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 4, 2024
Deafness due to loss of a TRPV channel eliminates mating behavior in <i>Aedes aegypti</i> malesYijin Wang, Dhananjay Thakur, Emma Duge, et al.
Journal of Experimental Child Psychology|June 16, 2017
Young infants' visual fixation patterns in addition and subtraction tasks support an object tracking accountJ Gavin Bremner, Alan M Slater, Rachel A Hayes, et al.
Trials|March 26, 2024
The ARIA trial protocol: a randomised controlled trial to assess the clinical, technical, and cost-effectiveness of a cloud-based, ARtificially Intelligent image fusion system in comparison to standard treatment to guide endovascular Aortic aneurysm repairJames Budge, Tom Carrell, Medeah Yaqub, et al.
Lancet (London, England)|May 13, 2017
Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trialSobha Sivaprasad, A Toby Prevost, Joana C Vasconcelos, et al.
Pageof 9